Market Research Reports

1. Central and Eastern Europe OTC Drugs Market Introduction

1.1. Central and Eastern Europe OTC Drugs Market Size by Revenue, 2006-2012

2. Central and Eastern Europe OTC Drugs Market Segmentation, 2006-2012

2.1. By Product Categories, 2006-2012

2.2. By Geography, 2006-2012

3. Trends and Developments in Central and Eastern Europe Market

Mergers and Acquisitions in OTC Market in Central and Eastern Europe

Liberalization of OTC Drugs Distribution in 2011 in CEE

Online Sales of Drugs Permitted in Slovakia

Rearrangement of the Wholesale Market of Pharmaceuticals in the Region

Online sales of Drugs allowed in Bulgaria

4. Central and Eastern Europe OTC Drugs Market Future Outlook and Projections, 2013-2017

4.1. Central and Eastern Europe OTC Drugs Market Future Projections, 2013-2017

4.1.1. By Geography, 2013-2017

4.1.2. Cause and Effect Relationship Between Industry Factors and Central and Eastern Europe OTC Drugs Market Prospects

5. Russia OTC Drugs Market Introduction

5.1. Russia OTC Drugs Market Size, 2006-2012

5.1.1. By Revenue, 2006-2012

5.1.2. By Volume, 2008-2012

5.2. Russia OTC Drugs Market Segmentation, 2006-2012

5.2.1. By Cold and Cough, Analgesics, Digestives, Skin Products, Vitamins and Minerals and Others, 2006-2012

5.2.2. By Cities, 2012

5.3. Trends and Developments in Russia OTC Drugs Market

Approval of Selling of OTC Drugs in retail stores by Ministry of Healthcare

Appointment of New Government: Spurring Developments in Health Sector in Russia

Increasing Focus on Bio-Additives and Functional Nutrition

5.4. Government Regulations in Russia OTC Drugs Industry

Ban on Over the Counter Sales of Medical Drugs

Major Regulatory Changes in Russian Pharmaceutical Market in 2012

5.5. Market Share of Major Players in Russia OTC Drugs Market, 1H2013

5.5.1. By Anti Cold and Flu Drugs, 2012

5.5.2. By Non- Narcotic Analgesics and Antipyretic Drugs, 2012

5.5.3. By Expectorants & Antitussives (Cough Medications), 2012

5.5.4. By Multivitamins with Minerals, 2012

5.5.5. By Systematic Agents for Fungal Infections, 2012

5.6. Competitive Landscape of Major Players in RussiaOTC Drugs Market

5.7. Russia OTC Drugs Market Future Outlook andProjections, 2013-2017

5.8. Macro Economic Factors of Russia OTC Drugs Market: Historical and Projected

5.8.1. Population, 2006-2017

5.8.2. Public and Private Health Expenditure, 2006-2017

5.8.3. Consumer Price Index on Medicines, 2010-2012

6. Poland OTC Drugs Market Introduction

6.1. Poland OTC Drugs Market Size, 2006-2012

6.2. Poland OTC Drugs Market Segmentation, 2006-2012

6.2.1. By Products, 2006-2012

6.2.2. By Pharmacy and Non-Pharmacy Distribution Channel, 2011

6.3. Trends and Developments in Poland OTC Drugs Market

Rising Advertisement Expenditure by Pharmaceutical Companies

Plans to Launch New Products by Dietary Supplements Manufacturers

6.4. Government Regulations in Poland Pharmaceutical Market

General Overview

Reimbursement Act, 2012

6.5. Market Share of Major Players in Poland OTC Drugs Market, 2012

6.6. Competitive Landscape of Major Players in Poland OTC Drugs Market

6.7. Poland OTC Drugs Market Future Outlook and Projections, 2013-2017

6.8. Macro Economic Factors of Poland OTC Drugs Market: Historical and Projected

6.8.1. Population, 2006-2017

6.8.2. Health Expenditure Per Capita, 2006-2017

6.8.3. Consumer Price Index on Health, 2006-2012

6.8.4. Number of Pharmacies in Poland, 2006-2017

7. Ukraine OTC Drugs Market Introduction

7.1. Ukraine OTC Drugs Market Size, 2006-2012

7.2. Ukraine OTC Drugs Market Segmentation, 2006-2012

7.2.1. By Products, 2006-2012

7.3. Trends and Developments in Ukraine OTC Drugs Market

First Reading in Parliament on Act on Ban of Advertisement of OTC Medications in 2011

Act on Ban of Advertisements of OTC Medications Passed in 2012

Rapidly Changing Lifestyles Spurring OTC Drugs Sales

7.4. Government Regulations in Ukraine OTC Drugs Market

Permitting Drug Retail Only through Pharmacies

Rules Pertaining to Promotional Activities of Drugs

Recent Developments in Legal Regulation of Medicine and Healthcare in Ukraine

7.5. Market Share of Major Players in Ukraine OTC Drugs Market, 2012

7.6. Competitive Landscape of Major Players in Ukraine OTC Drugs Market

7.7. Ukraine OTC Drugs Market Future Outlook and Projections, 2013-2017

7.8. Macro Economic Factors of Ukraine OTC Drugs Market: historical and Projected

7.8.1. Population, 2006-2017

7.8.2. Health Expenditure of Households, 2006-2017

7.8.3. Consumer Price Index on Health, 2006-2012

8. The Czech Republic OTC Drugs Market Introduction

8.1. The Czech Republic OTC Drugs Market Size, 2006-2012

8.2. The Czech Republic OTC Drugs Market Segmentation, 2006-2012

8.2.1. By Products, 2006-2012

8.3. Trends and Developments in the Czech Republic OTC Drugs Market

Enactment of Reforms to Encourage Patients to Take greater Responsibility for Medical Treatment

Policies Geared Towards Reducing Costs in Healthcare

Restricted Development in 2008 due to Imposition of Mandatory Fees on Doctor Visit’s

Surging Investments in the Pharmaceutical Sector

8.4. Government Regulations on the Czech Republic Pharmaceutical Industry

General Overview

Mandatory Registration on Drugs for Manufacturing and Marketing

General Provisions on Promotion of Medicinal Products in the Market

8.5. Competitive Landscape of Major Players in the Czech Republic OTC Drugs Market

8.6. The Czech Republic OTC Drugs Market Future Outlook and Projections, 2013-2017

8.7. Macro Economic Factors of the Czech Republic OTC Drugs Market

8.7.1. Population, 2006-2017

8.7.2. Health Expenditure of Households, 2006-2017

8.7.3. Number of Pharmacies in the Czech Republic, 2006-2012

8.7.4. GDP (FROM Production Side), 2006-2017

9. Romania OTC Drugs Market Introduction

9.1. Romania OTC Drugs Market Size by Revenue and Volume, 2006-2012

9.2. Romania OTC Drugs Market Segmentation, 2006-2012

9.2.1. By Products, 2006-2012

9.3. Implication of Claw Back System in RomaniaPharmaceutical Industry

9.4. Trends and Developments in Romania OTC Drugs Market

Introduction of Clawback System Resulting in Rise in OTC Drugs Sales

Trends in Production of Pharmaceutical Drugs

9.5. Government Regulations in Romania Pharmaceutical Industry

Regulatory Framework: A General Overview

Pricing and Reimbursement Methodology

Pharmacy Law

9.6. Revenues of Top 10 Pharmaceutical Companies in Romania by Sales Value of OTC Cold and Flu Drugs, 2012

9.7. Romania OTC Drugs Market Future Outlook and Projections, 2013-2017

9.8. Macro Economic Factors of Romania OTC Drugs Market: Historical and Projected

9.8.1. Population, 2006-2017

9.8.2. Health Expenditure of Households, 2006-2017

9.8.3. Number of Pharmacies and Pharmaceutical Points in Romania, 2006-2017

10. Snapshot of Countries in OTC Drugs Market in Central and Eastern Europe

10.1. Hungary

10.1.1. Hungary OTC Drugs Market Size and Segmentation, 2006-2012

10.1.2. Distribution Channels of OTC Drugs in Hungary, 2012

10.1.2.1. Major OTC Products Sold in Pharmacies in Hungary, 2012

10.1.3. Recent Trends and Developments in Hungary OTC Drugs Market

Pharmacies in Hungary Permitted to Sell OTC Drugs Online

Reduced Spending by Pharmaceutical Companies in Hungary on Medical Journals in 2011

10.1.4. Hungary Pharmaceutical Regulatory Environment

Peculiar Taxes

Regulatory Framework Related to Opening of Pharmacies in Hungary

Regulations on Prices

Research and Development Based Tax Allowances

10.1.5. Market Share of Leading Players in Hungary OTC Drugs Market, 2012

10.1.6. Recent Developments of Companies in Hungary OTC Drugs Market

Government to co-found a company with vaccine manufacturer Omninvest

Gedeon Richter establishes new joint venture in China

Egis considering more than one acquisition

10.1.7. Hungary OTC Drugs Market Future Outlook and Projections, 2013-2017

10.2. Slovakia

10.2.1. Slovakia OTC Drugs Market Size and Segmentation, 2006-2012

10.2.2. Recent Trends and Developments in Slovakia OTC Drugs Market

Online Sales of OTC Drugs Permitted in Slovakia

Pricing structure

10.2.3. Slovakia OTC Drugs Future Outlook and Projections, 2013-2017

10.3. Bulgaria

10.3.1. Current Position, 2012

10.3.2. Bulgaria OTC Drugs Market Size and Segmentation, 2006-2012

10.3.3. Recent Trends and Developments in Bulgaria OTC Drugs Market

Legal Approval of Online Sales of OTC Drugs in Bulgaria

Bulgaria Pharma Market: 2012 Trends

10.3.4. Government Regulations in Bulgaria Pharmaceutical Market

Pricing System

10.3.5. Competitive Scenario of Major Players in Bulgaria OTC drugs Market

10.3.6. Bulgaria OTC Drugs Market Future Outlook and Projections, 2013-2017

11. Appendix

11.1. Market Definitions

11.2. Abbreviations

11.3. Research Methodology

Data Collection Methods

Approach

Variables (Dependent and Independent) 

Multi Factor Based Sensitivity Model

Final Conclusion

11.4. Disclaimer

To know more information on Purchase by Section, please send a mail toinfo@kenresearch.com